GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Current Accrued Expense

U2Bio Co (XKRX:221800) Current Accrued Expense : ₩0 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Current Accrued Expense?

U2Bio Co's Current Accrued Expense for the quarter that ended in Jun. 2024 was ₩0 Mil.


U2Bio Co Current Accrued Expense Historical Data

The historical data trend for U2Bio Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Current Accrued Expense Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only - - - - -

U2Bio Co Quarterly Data
Jun22 Mar23 Jun23 Mar24 Jun24
Current Accrued Expense - - - - -

U2Bio Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


U2Bio Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co Headlines

No Headlines